Jeffrey J. Pu
0000-0001-7498-3159
Publication & Citation Trends
Most Cited Works
Publications
123 total
COVID-19 in patients with CLL: improved survival outcomes and update on management strategies PDF
Cited by 70
OpenAlex
Novel agents and regimens for hematological malignancies: recent updates from 2020 ASH annual meeting PDF
Cited by 66
OpenAlex
Outcomes of COVID-19 in patients with CLL: a multicenter international experience PDF
Cited by 318
OpenAlex
Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy PDF
Cited by 113
OpenAlex
Alternative Polyadenylation: a new frontier in post transcriptional regulation PDF
Cited by 95
OpenAlex
Toxicities and outcomes of 616 ibrutinib-treated patients in the United States: a real-world analysis PDF
Cited by 446
OpenAlex
Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States PDF
Cited by 163
OpenAlex
Outcomes of front‐line ibrutinib treated CLL patients excluded from landmark clinical trial PDF
Cited by 71
OpenAlex
Research Topics
Chronic Lymphocytic Leukemia Research
(37)
Lymphoma Diagnosis and Treatment
(24)
Acute Myeloid Leukemia Research
(14)
Complement system in diseases
(13)
Hematopoietic Stem Cell Transplantation
(11)
Frequent Co-Authors
Affiliations
Brigham and Women's Hospital
Boston Medical Center
Pennsylvania State University
New York Blood Center
Harvard University